0001127602-14-012478.txt : 20140321 0001127602-14-012478.hdr.sgml : 20140321 20140321161751 ACCESSION NUMBER: 0001127602-14-012478 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140320 FILED AS OF DATE: 20140321 DATE AS OF CHANGE: 20140321 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DORSA CAROLINE CENTRAL INDEX KEY: 0001181174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 14710444 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-03-20 0000875045 BIOGEN IDEC INC. BIIB 0001181174 DORSA CAROLINE BIOGEN IDEC INC. 225 BINNEY STREET CAMBRIDGE MA 02142 1 Common Stock 2014-03-20 4 M 0 10000 53.64 A 24468 D Common Stock 2014-03-20 4 S 0 2200 347.283 D 22268 D Common Stock 2014-03-20 4 S 0 2701 348.662 D 19567 D Common Stock 2014-03-20 4 S 0 4199 349.541 D 15368 D Common Stock 2014-03-20 4 S 0 900 350.368 D 14468 D Stock Option (Right to Buy) 53.64 2014-03-20 4 M 0 10000 0 D 2020-01-03 Common Stock 10000 25000 D Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934 This represents the weighted average price for shares purchased at a range between $347.06 (low) and $347.95 (high). Full information regarding the number of shares purchased at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer. This represents the weighted average price for shares purchased at a range between $348.09 (low) and $349.06 (high). This represents the weighted average price for shares purchased at a range between $349.11 (low) and $350.08 (high). This represents the weighted average price for shares purchased at a range between $350.11 (low) and $350.85 (high). The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 01/04/2010. Matthew S. Gilman, Attorney in Fact for Caroline D. Dorsa 2014-03-21